AI Prospecting for Eli Lilly
Company data:
Company size:
43000 employeesWebsite URL:
https://www.lilly.comIndustry
PharmaceuticalsHeadquarters:
Indianapolis, Indiana, USAInvestment round:
NYSE: LLYARR:
N/AKey stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about Eli Lilly
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Eli Lilly announced positive Phase 3 trial results for orforglipron, the first oral small molecule GLP-1 receptor agonist, which reduced A1C by 1.3-1.6% and weight by 16 pounds. The drug is set for FDA submission for type 2 diabetes in 2026 and for weight management by the end of 2025[3][4][5].
Eli Lilly's stock surged 16% after announcing positive Phase 3 trial results for its oral GLP-1 pill, orforglipron, which showed statistically significant effectiveness in reducing A1C and facilitating weight loss, with plans for FDA submission in 2026 for type 2 diabetes and by the end of 2025 for weight management[3][5].
Eli Lilly will announce its first-quarter 2025 financial results on May 1, 2025, and will conduct a conference call to detail the company's financial performance[2][3][4].
Open job positions at Eli Lilly
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Technical Product Manager - Associate Director
Automation Support Engineer - RPA Specialty
Senior Associate Manager Regulatory Writing
